Aurora Labs Launches a $6m Placement to Scale Defence Engine Output

Aurora Labs has locked in a $6 million defence propulsion placement at $0.055 a share, backed by Walkinshaw and its own Chairman, to turn its AS9100D-certified turbojet technology into scaled production.
By Josua Ferreira -
  • Aurora Labs has secured $6 million through 109.1 million new shares at $0.055, a 6.77% discount to the last trade of $0.059 and about 20.8% of current shares on issue.
  • Tranche 1 of $4.565 million settles on 2 November 2026, while the $1.435 million Tranche 2 hinges on a General Meeting in mid-January 2027.
  • Walkinshaw Group Holdings has made a significant strategic investment, opening a pathway to production support talks given its manufacturing scale-up experience.
  • Chairman David Trimboli is committing $550,000, subject to shareholder approval.
  • Proceeds target turbojet line expansion, commercial metal additive equipment and full-rate production readiness, building on AS9100D certification, an MBDA Teaming Agreement and a maiden US order.
Summarise with AI:

Aurora Labs secures $6m placement to scale defence propulsion manufacturing

Aurora Labs Limited (ASX: A3D) has secured firm commitments to raise $6m (before costs) through the issue of 109.1m new fully paid ordinary shares at $0.055. The commitments come from institutional, sophisticated and professional investors, and the announcement is intended to lift the company’s trading halt.

The Placement includes a $550,000 commitment from Non-Executive Chairman Mr David Trimboli (subject to shareholder approval) and a “significant strategic investment” from Walkinshaw Group Holdings Pty Ltd. Funds will support the transition from technology development towards scaled commercial manufacturing of Aurora’s proprietary propulsion systems.

Inside the placement: pricing and two tranches

Pricing and structure

The issue price of $0.055 represents a 3.67% discount to the 10-day VWAP (volume weighted average price), a 3.16% discount to the 5-day VWAP and a 6.77% discount to the last trading price of $0.059 on 23 October 2026. The New Shares represent ~20.8% of the current shares on issue.

Aurora Labs $6M Placement Structure

No lead manager or advisor was appointed, with Aurora’s management conducting the Placement. Participating brokers will be issued a total of 7.5m options, along with cash fees totalling $213k. Each option has an exercise price of $0.12, expires three years from the date of issue and is not transferable.

The Placement will be completed in two tranches:

Tranche Amount New Shares Authority Timing
Tranche 1 $4,565,000 83,000,005 30.64m under ASX Listing Rule 7.1; 52.36m under ASX Listing Rule 7.1A Settlement expected 2 November 2026; allotment scheduled 4 November 2026
Tranche 2 $1,435,000 26,090,914 Subject to shareholder approval at a General Meeting General Meeting to be convened in mid-January 2027

Walkinshaw’s strategic role

Walkinshaw is part of an Australian-headquartered engineering group with capabilities across design, engineering, development, commercialisation and contract manufacturing for global customers.

According to Aurora, the investment creates a pathway for discussions with Walkinshaw on future production support, given its experience in manufacturing scale up. It also opens the potential for Aurora to support Walkinshaw in metal additive production.

Where the money goes

Proceeds will be applied towards accelerating manufacturing expansion and supporting continued commercialisation of Aurora’s proprietary defence propulsion technologies, including:

  1. Expansion of existing production lines to support higher-volume turbojet engine production
  2. Acquisition of commercial off-the-shelf metal additive manufacturing equipment
  3. Product readiness, including finalisation of production data packs and investment in scalable systems, processes and key personnel to support the transition to full-rate production
  4. Business development and marketing across defence and aerospace markets
  5. Ongoing intellectual property protection, patent management and maintenance of technical and commercial data rooms
  6. Maintaining AS9100D aerospace quality certification and associated compliance requirements
  7. General working capital and costs associated with the Placement

The funding will support Aurora’s strategy to establish a scalable, vertically integrated manufacturing platform capable of supplying advanced propulsion systems to defence and aerospace customers in Australia and internationally. It leverages the company’s AS9100D-certified manufacturing facility in Western Australia.

Why additive manufacturing matters for defence supply

Metal additive manufacturing, often called 3D metal printing, builds parts layer by layer rather than cutting them from solid blocks. Aurora applies the approach to its proprietary additively manufactured turbojet propulsion systems, and is developing advanced propulsion systems for Unmanned Aerial Systems (UAS) for the Defence sector.

For investors, the focus is on higher production volumes and operational efficiency. Aurora says the funding will strengthen its readiness to support increasing demand for sovereign propulsion technologies.

The Defence Industry Development Grant is being matched dollar-for-dollar by Aurora to commission a large-format commercial metal 3D printer at Canning Vale, a hybrid model that keeps proprietary R&D machines focused on development while volume production shifts to off-the-shelf equipment.

Momentum behind the raise

The Placement follows a period of operational and commercial progress for Aurora, including:

  • Achievement of AS9100D aerospace quality certification
  • Commencement of commercial AU4 propulsion system deliveries
  • Receipt of $1m in Defence Industry Development Grant funding
  • Execution of a strategic Teaming Agreement with global defence company MBDA
  • A maiden US propulsion system order, providing an initial commercial entry into the US aerospace and defence market

The maiden US propulsion order covered three AU4 turbojets plus integration services for an unnamed US start-up, a small initial value that nonetheless opens a new market, with any follow-on business dependent on successful integration and a separate commercial agreement.

Mr David Trimboli, Non-Executive Chairman

“…Our focus is now firmly on converting this progress into increased production volumes, additional customer contracts and sustainable commercial growth.”

What happens next for Aurora Labs

The announcement sets out the following dates:

  1. Tranche 1 settlement: expected on 2 November 2026.
  2. Tranche 1 allotment: scheduled for 4 November 2026.
  3. General Meeting: to be convened by the company in mid-January 2027, with Tranche 2 ($1,435,000) subject to shareholder approval at that meeting.

The Chairman’s $550,000 commitment is separately subject to shareholder approval.

With the Placement commitments secured, Aurora has capital directed at converting its defence and aerospace pipeline into production volumes.

Get Defence Tech News Before the Market Moves

Join 20,000+ investors receiving FREE breaking ASX news within minutes of release, complete with in-depth analysis already done. Click the “Free Alerts” button at Big News Blast to get industrial and defence announcements in your inbox the moment they break, and stay ahead of the market.


Frequently Asked Questions

What is the Aurora Labs defence propulsion placement?

Aurora Labs (ASX: A3D) has secured firm commitments to raise $6 million by issuing 109.1 million new shares at $0.055 each. The money will fund the shift from technology development to scaled manufacturing of its defence propulsion systems.

What is a placement in ASX share markets?

A placement is a capital raising where a company issues new shares directly to institutional, sophisticated and professional investors rather than offering them to all shareholders. Aurora's placement is split into two tranches, with the second needing shareholder approval.

When will Aurora Labs placement shares be issued?

Tranche 1 settlement is expected on 2 November 2026, with allotment scheduled for 4 November 2026. Tranche 2, worth $1.435 million, depends on shareholder approval at a General Meeting in mid-January 2027.

Who is Walkinshaw and why is it investing in Aurora Labs?

Walkinshaw Group Holdings is an Australian-headquartered engineering group with design, development and contract manufacturing capabilities. Its strategic investment creates a pathway to discuss future production support and potential metal additive production work with Aurora.

What will Aurora Labs use the $6 million for?

Aurora will expand production lines for turbojet engines, buy commercial metal additive manufacturing equipment and prepare products for full-rate production. Funds will also cover business development, IP protection, AS9100D certification upkeep and working capital.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher